Benchling has launched its inaugural 2023 State of Tech in Biopharma report, which has shed light on the obstacles that biopharma encounter when striving to fully implement and embrace these technologies.  The report surveyed 300 R&D and IT experts from biopharma companies large and small to do a first-ever investigation into biopharma’s use of an… Read more »

The post 2023 State of Tech in Biopharma report reveals tech strategies in era of data and AI  appeared first on Cloud Computing News.